Medical/Pharmaceuticals

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

* SAGE Healthcare Private Limited appointed to serve as a non-exclusive licensee and distributor for Volition's Nu.Q® Vet Cancer Screening Test in centralized labs inSingapore, with launch planned in Singapore in the first quarter of 2022 followed by expansion in conjunction with SAGE Healthcar...

2021-12-16 21:00 3713

Gracell Biotechnologies Selected for Addition to NASDAQ Biotechnology Index

SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Dec. 16, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment o...

2021-12-16 21:00 3383

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

TAIZHOU, China, Dec. 16, 2021 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"),(NASDAQ: SXTC) announced today that on December 14, 2021, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notif...

2021-12-16 21:00 2605

Launching the world's first all-in-one medical and welfare VR platform JOLLYGOOD+

TOKYO, Dec. 16, 2021 /PRNewswire/ -- Jolly Good Inc. ("Jolly Good") will begin providing JOLLYGOOD+, an all-in-one medical and welfare VR platform that integrates medical education VR for medical staff training, nursing care training VR, social skills training (SST) VR, and recreational VR.

2021-12-16 21:00 2404

Senhwa Clinical Data Abstract for Silmitasertib in Patients with Advanced Basal Cell Carcinoma Accepted for 2022 AAD Annual Meeting

TAIPEI and SAN DIEGO, Dec. 16, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that an abstract highlighting preliminary clinical data for their lead drug...

2021-12-16 20:00 2938

Huawei supports Thailand launch 5G Smart Hospital

BANGKOK, Dec. 16, 2021 /PRNewswire/ -- Thailand Office of The National Broadcasting and Telecommunications Commission (NBTC), Siriraj Hospital, and Huawei Technologies (Thailand) Co., Ltd. on Thursday jointly launched the "Siriraj World Class 5G Smart Hospital."

2021-12-16 19:03 3330

Bionomics Limited Announces Pricing of Initial Public Offering in the United States

ADELAIDE, Australia, Dec. 16, 2021 /PRNewswire/ -- Bionomics Limited (Bionomics orCompany), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering inthe United States (the Offering) of 1,622,000 American Depositary Shares (ADSs), each representing 1...

2021-12-16 19:00 3491

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

MACAU, Dec. 16, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang Wu Hospital, one of the largest and oldest hospitals inMacau to advance smart health application and research with AI.

2021-12-16 18:01 3508

BINUS SCHOOL Simprug Announces Students' Participation in an International Scientific Publication about COVID-19

JAKARTA, Indonesia, Dec. 16, 2021 /PRNewswire/ -- BINUS SCHOOL Simprug, an International Baccalaureate (IB)World School in Indonesia, announces that 15 of their high school students have participated in the creation of a scientific journal titledVoice Processing for COVID-19 Scanning and Progn...

2021-12-16 17:02 3379

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

MACAU, Dec. 16, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang Wu Hospital, one of the largest and oldest hospitals inMacau to advance smart health application and research with AI.

2021-12-16 16:58 4691

Antengene and XtalPi Announce AI-Driven R&D Collaboration

SHANGHAI and HONG KONG, Dec. 16, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life...

2021-12-16 16:30 4505

BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021

Advances in Alzheimer's, innovation in DNA vaccines, increased regulatory collaboration and the evolving impact of Artificial Intelligence, join Covid-19 as key stories and trends of 2021 LONDON, Dec. 16, 2021 /PRNewswire/ -- BioWorld published by Clarivate Plc  (NYSE:CLVT), a global leader in pr...

2021-12-16 16:14 2939

Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study

Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors LAUSANNE, Switzerland, Dec. 16, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss biopharmaceutica...

2021-12-16 16:00 2670

PHASE 3 TRIAL OF SHR8058 EYE DROPS (PERFLUOROHEXYLOCTANE) CONDUCTED BY JIANGSU HENGRUI PHARMACEUTICALS IN THE PEOPLE'S REPUBLIC OF CHINA SHOWS STATISTICALLY SIGNIFICANT TOPLINE RESULTS

HEIDELBERG, Germany, and CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops ...

2021-12-16 15:00 2801

French Neurosurgeon and Physicist Dr. Alim Louis Benabid, Recipient of 42nd Honda Prize, Honored at Online Award Ceremony

TOKYO, Dec. 16, 2021 /PRNewswire/ -- The Honda Foundation, based in Tokyo, is pleased to announce that the 42nd Honda Prize Award Ceremony was held on Wednesday, November 17, 2021, and awarded this year's prize to Dr. Alim Louis Benabid, emeritus professor at the Joseph Fourier University and chai...

2021-12-16 15:00 2003

LifeTech and Medtronic Further Strategic Collaboration to Open New Chapter of Domestically-Made MRI-Conditional Pacemakers

SHENZHEN, China, Dec. 16, 2021 /PRNewswire/ -- LifeTech Scientific Corporation (LifeTech, 01302.HK) announced that it has extended its agreements with Medtronic to further the strategic collaboration on the "HeartTone™ domestic pacemaker project" and to start the collaboration on domestically-mad...

2021-12-16 12:41 5175

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine

-- Takeda submits application for TAK-019/NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for NDA, toJapan's Ministry of Health, Labour and Welfare (MHLW) -- Interim data from Phase 1/2 trial in Japan demonstrate robust immune response and favorable tolerability with no serious a...

2021-12-16 12:03 3434

The Clinician begins rollout of patient-reported outcome and experience measures for the Singapore public healthcare system

SINGAPORE, Dec. 16, 2021 /PRNewswire/ -- The Clinician , a global digital health leader, has partnered with Singapore's HealthTech agency, Integrated Health Information Systems (IHiS), to launch an electronic patient-reported outcome and experience measures (PROMs and ...

2021-12-16 10:20 4729

Prenetics Launches Circle Healthpod At Hong Kong International Airport, Providing Travellers With Rapid COVID-19 PCR Quality Results In Less Than 60 Minutes

* Results Available In the Form of Digital Health Passport, SMS and Email * HealthPod Results Accepted by 13 Countries as Valid Pre-Departure COVID-19 Test:USA, Canada, UK, Spain, Germany, Italy, Netherlands, Sweden, Luxembourg, New Zealand, South Korea and more * Circle HealthPod, with Te...

2021-12-16 09:00 4232

Everest Medicines announces FDA grants our Partner Calliditas Therapeutics Accelerated Approval of TARPEYO™ (budesonide) to Reduce Proteinuria in IgA Nephropathy

* TARPEYO (budesonide) delayed release capsules is the first and only treatment indicated to reduce proteinuria in adults withprimary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5g/g1 * TARPEYO (developed un...

2021-12-16 08:49 5164
1 ... 608609610611612613614 ... 643